- Home
- NBTX vs LASR Comparison
NBTX vs LASR Comparison
Compare NBTX & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- LASR
- Stock Information
- Founded
- NBTX 2003
- LASR 2000
- Country
- NBTX France
- LASR United States
- Employees
- NBTX N/A
- LASR N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- LASR Semiconductors
- Sector
- NBTX Health Care
- LASR Technology
- Exchange
- NBTX Nasdaq
- LASR Nasdaq
- Market Cap
- NBTX 868.8M
- LASR 903.8M
- IPO Year
- NBTX 2020
- LASR 2018
- Fundamental
- Price
- NBTX $27.75
- LASR $32.25
- Analyst Decision
- NBTX Strong Buy
- LASR Strong Buy
- Analyst Count
- NBTX 1
- LASR 6
- Target Price
- NBTX $8.00
- LASR $27.42
- AVG Volume (30 Days)
- NBTX 162.1K
- LASR 861.7K
- Earning Date
- NBTX 09-30-2025
- LASR 11-06-2025
- Dividend Yield
- NBTX N/A
- LASR N/A
- EPS Growth
- NBTX N/A
- LASR N/A
- EPS
- NBTX N/A
- LASR N/A
- Revenue
- NBTX $11,930,711.00
- LASR $216,913,000.00
- Revenue This Year
- NBTX N/A
- LASR $23.44
- Revenue Next Year
- NBTX $114.97
- LASR $8.73
- P/E Ratio
- NBTX N/A
- LASR N/A
- Revenue Growth
- NBTX N/A
- LASR 9.79
- 52 Week Low
- NBTX $2.76
- LASR $6.20
- 52 Week High
- NBTX $30.35
- LASR $32.27
- Technical
- Relative Strength Index (RSI)
- NBTX 66.10
- LASR 60.54
- Support Level
- NBTX $23.31
- LASR $28.22
- Resistance Level
- NBTX $29.72
- LASR $30.95
- Average True Range (ATR)
- NBTX 2.12
- LASR 1.44
- MACD
- NBTX 0.66
- LASR -0.09
- Stochastic Oscillator
- NBTX 80.80
- LASR 87.95
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About LASR nLIGHT Inc.
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.